Page last updated: 2024-08-23

diisopropanolnitrosamine and Intestinal Diseases

diisopropanolnitrosamine has been researched along with Intestinal Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hasumura, M; Hirose, M; Imai, T; Onose, J; Takizawa, T	1

Other Studies

1 other study(ies) available for diisopropanolnitrosamine and Intestinal Diseases

Article	Year
Indomethacin induces small intestinal damage and inhibits amitrole-associated thyroid carcinogenesis in rats initiated with N-bis(2-hydroxypropyl)nitrosamine. Toxicology letters, 2006, Jun-20, Volume: 164, Issue:1 Topics: Amitrole; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Carcinogens; Cocarcinogenesis; Indomethacin; Intestinal Diseases; Male; Nitrosamines; Organ Size; Rats; Rats, Inbred F344; Thyroid Gland; Thyroid Hormones; Thyroid Neoplasms	2006

Article

Year

Indomethacin induces small intestinal damage and inhibits amitrole-associated thyroid carcinogenesis in rats initiated with N-bis(2-hydroxypropyl)nitrosamine.

Toxicology letters, 2006, Jun-20, Volume: 164, Issue:1

Topics: Amitrole; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Carcinogens; Cocarcinogenesis; Indomethacin; Intestinal Diseases; Male; Nitrosamines; Organ Size; Rats; Rats, Inbred F344; Thyroid Gland; Thyroid Hormones; Thyroid Neoplasms

2006